2017-10-11 19:20:44 UTC

Duration of Hepatitis C Virus Therapy

Oct. 11, 2017

Shorter duration therapy reduces treatment costs and may also improve adherence. How short can therapy be and who would qualify?

Guidelines for the treatment of chronic hepatitis C virus (HCV) do not encourage treatment for less than 12 weeks. Benjamin Emmanuel, MPH, Eleanor M. Wilson, MD, and Shyam Kottilil, MD, PhD, explain in AGA Perspectives that there is mounting evidence that many patients can achieve sustained virologic response with only eight weeks of treatment. The shorter duration therapy substantially reduces treatment costs and may also improve adherence as adherence tends to decrease as therapy duration increases. 

The authors recommend further exploration into shorter HCV therapy in target populations to address some of the issues that may arise, such as optimal retreatment strategies and the emergence of resistance-associated variants. 

Read the full article in AGA Perspectives.

More on Hepatitis C

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

Final days to save on AGA Postgraduate Course

April 10, 2018

Early bird deadline is April 18 – last chance to save $75.